Cited by CrossRef (12)

  1. Ifeanyichukwu Ogobuiro, Amber L. Collier, Khadeja Khan, Iago de Castro Silva, Deukwoo Kwon, Gregory C. Wilson, Patrick B. Schwartz, Alexander A. Parikh, Chet Hammill, Hong J. Kim, David A. Kooby, Daniel Abbott, Shishir K. Maithel, Rebecca A. Snyder, Syed A. Ahmad, Nipun B. Merchant, Jashodeep Datta. Racial Disparity in Pathologic Response following Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: A Multi-Institutional Analysis from the Central Pancreatic Consortium. Ann Surg Oncol 2023;30:1485
    https://doi.org/10.1245/s10434-022-12741-4
  2. Monica Chase, Howard S Friedman, Seongjung Joo, Prakash Navaratnam. Adjuvant and Neoadjuvant Treatment Patterns among Resectable Pancreatic Cancer Patients in the USA. Future Oncol. 2022;18:3929
    https://doi.org/10.2217/fon-2021-1583
  3. Parsa Lorestani, Mohsen Dashti, Negar Nejati, Mohammad Amin Habibi, Mandana Askari, Behruz Robat-Jazi, Sajjad Ahmadpour, Soheil Tavakolpour. The complex role of macrophages in pancreatic cancer tumor microenvironment: a review on cancer progression and potential therapeutic targets. Discov Onc 2024;15
    https://doi.org/10.1007/s12672-024-01256-x
  4. Hai-Yan Pan, Xiao-Wei Wang, Qiong-Xiao He, Yi-Dan Lu, Wan-Yi Zhang, Jian-Wei Jin, Bin Lin. Efficacy and safety of gastroscopic hemostasis in the treatment of acute gastric hemorrhage: A meta-analysis. World J Gastrointest Oncol 2023;15:1988
    https://doi.org/10.4251/wjgo.v15.i11.1988
  5. Henrique A. Lima, Laura Alaimo, Zorays Moazzam, Yutaka Endo, Selamawit Woldesenbet, Erryk Katayama, Muhammad Musaab Munir, Chanza Shaikh, Samantha M. Ruff, Mary Dillhoff, Joal Beane, Jordan Cloyd, Aslam Ejaz, Vivian Resende, Timothy M. Pawlik. Disparities in NCCN Guideline-Compliant Care for Patients with Early-Stage Pancreatic Adenocarcinoma at Minority-Serving versus Non-Minority-Serving Hospitals. Ann Surg Oncol 2023;30:4363
    https://doi.org/10.1245/s10434-023-13230-y
  6. Marcus Steingrüber, Yousef Moulla, Timm Denecke, Hans-Jonas Meyer. Modern radiological assessment after neoadjuvant therapy in pancreatic cancer: an overview. 2024;7:207
    https://doi.org/10.1097/JP9.0000000000000156
  7. Elliott J. Yee, Robert J. Torphy, Otto N. Thielen, Lavanya Easwaran, Oskar Franklin, Toshitaka Sugawara, Christan Bartsch, Nicole Garduno, Martin M. McCarter, Steven A. Ahrendt, Richard D. Schulick, Marco Del Chiaro. Radiologic Occult Metastases in Pancreatic Cancer: Analysis of Risk Factors and Survival Outcomes in the Age of Contemporary Neoadjuvant Multi-agent Chemotherapy. Ann Surg Oncol 2024;31:6127
    https://doi.org/10.1245/s10434-024-15443-1
  8. Jufeng Sun, Jennifer R. Baker, Cecilia C. Russell, Hong N. T. Pham, Chloe D. Goldsmith, Peter J. Cossar, Jennette A. Sakoff, Christopher J. Scarlett, Adam McCluskey. Novel piperazine-1,2,3-triazole leads for the potential treatment of pancreatic cancer. RSC Med. Chem. 2023;14:2246
    https://doi.org/10.1039/D2MD00289B
  9. Wei Liu, Tiansong Xie, Lei Chen, Wei Tang, Zehua Zhang, Yu Wang, Weiwei Deng, Xuebin Xie, Zhengrong Zhou. Dual-layer spectral detector CT: A noninvasive preoperative tool for predicting histopathological differentiation in pancreatic ductal adenocarcinoma. European Journal of Radiology 2024;173:111327
    https://doi.org/10.1016/j.ejrad.2024.111327
  10. Luis Marti-Bonmati, Leonor Cerdá-Alberich, Alexandre Pérez-Girbés, Roberto Díaz Beveridge, Eva Montalvá Orón, Judith Pérez Rojas, Angel Alberich-Bayarri. Pancreatic cancer, radiomics and artificial intelligence. BJR 2022;95
    https://doi.org/10.1259/bjr.20220072
  11. Alvaro Gregorio Morales Taboada, Pablo Lozano Lominchar, María Fernández Martínez, Pilar García-Alfonso, Andrés Muñoz Martin, Jose Manuel Asencio. Neoadjuvant therapy impact in early pancreatic cancer: “bioborderline” vs. “non-bioborderline”. Ann Hepatobiliary Pancreat Surg 2022;26:363
    https://doi.org/10.14701/ahbps.22-023
  12. Yi Chen, Tiansong Xie, Lei Chen, Zehua Zhang, Yu Wang, Zhengrong Zhou, Wei Liu. The preoperative prediction of lymph node metastasis of resectable pancreatic ductal adenocarcinoma using dual-layer spectral computed tomography. Eur Radiol 2024
    https://doi.org/10.1007/s00330-024-11143-2